Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake-Reference-Cited by-同舟云学术

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake

Published:2019-11 Issue:5 Volume:30 Page:987-996.e6
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Adriaenssens Alice E.,Biggs Emma K.,Darwish Tamana,Tadross John,Sukthankar Tanmay,Girish Milind,Polex-Wolf Joseph,Lam Brain Y.,Zvetkova Ilona,Pan Warren,Chiarugi Davide,Yeo Giles S.H.,Blouet Clemence,Gribble Fiona M.,Reimann Frank

Funder

Disease Model Core

Genomics and Transcriptomics Core

Histology Core

Imaging Core

Core Biochemical Assay Laboratory

MRC

Wellcome Trust

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference54 articles.

1. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand;Armbruster;Proc. Natl. Acad. Sci. USA,2007

2. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance;Ayala;Endocrinology,2010

3. Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice;Boylan;Am. J. Physiol. Endocrinol. Metab.,2015

4. Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man;Buchan;Histochemistry,1978

5. Identification of the intestinal cell storing gastric inhibitory peptide;Buffa;Histochemistry,1975

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirzepatide a novel anti diabetic molecule unfold dual action;Discover Public Health;2024-09-05

2. Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article;Indian Journal of Endocrinology and Metabolism;2024-09-04

3. A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy;Diabetes, Obesity and Metabolism;2024-08-27

4. Opportunities to optimize lifestyle interventions in combination with glucagon‐like peptide‐1‐based therapy;Diabetes, Obesity and Metabolism;2024-08-19

5. Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain;2024-08-16